dc.creatorLia Santarosa,Patricia
dc.creatorGranja,Fabiana
dc.creatorCristina Morari,Elaine
dc.creatorLeite,Janaína Luisa
dc.creatorVera Montalli da Assumpção,Ligia
dc.creatorWard,Laura S
dc.date2004-12-01
dc.date.accessioned2017-03-07T15:36:17Z
dc.date.available2017-03-07T15:36:17Z
dc.identifierhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004001200009
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/387971
dc.descriptionBackground: p53 is a nuclear protein that exerts an important role in the negative control of cellular proliferation, as well as in masterminding signaling cascades important in DNA repair and/or apoptosis. Mutations of p53 have been reported with high frequency in many cancer types and are highly prevalent in poorly differentiated and undifferentiated thyroid carcinomas, but they are not found in benign tumors and are infrequent in well-differentiated cancer. Most mutations are located in exons 5-8 of the gene. Recently, a germline mutation in the seldom investigated exon 10, on codon 337 of p53 was described in Brazilian children who had adrenocortical tumors. Aim: To study codon 337 of exon 10 of p53 mutation in thyroid tumors. Material and methods: Seventy four thyroid tumors were studied (5 follicular carcinomas including 3 widely invasive, 22 papillary carcinomas including 6 tall cell variants, 11 follicular adenomas, 1 medullary carcinoma and 35 benign goiters). DNA was extracted from a central part of all tumors and contralateral normal thyroid tissue samples or blood from 38 of these patients. The products of PCR for exon 10 of p53 were examined by single strand conformation polymorphism (SSCP) analysis. We sequenced 2 samples suspected of presenting aberrant migrating bands and 3 additional PCR products from tumor samples with normal SSCP patterns but all were wild type. Results: In all samples studied, a wild type sequence was found. Conclusions: Exon 10 of p53 gene does not present mutations in thyroid tumors, suggesting that this mutation is specific of adrenocortical cancers. (Rev Méd Chile 2004; 132: 1513-6)
dc.formattext/html
dc.languageen
dc.publisherSociedad Médica de Santiago
dc.sourceRevista médica de Chile v.132 n.12 2004
dc.subjectGenes, p53
dc.subjectMutation
dc.subjectThyroid gland
dc.subjectTumor protein p53-binding protein
dc.titleLack of mutation in exon 10 of p53 gene in thyroid tumors
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución